BINP Bionoid Pharma Inc

USD 0.20 0.00 0
Icon

Bionoid Pharma Inc (BINP) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.2

0.00 (0.00)%

USD 0.01B

N/A

N/A

N/A

Icon

BINP

Bionoid Pharma Inc (USD)
COMMON STOCK | OTC
USD 0.20
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.01B

N/A

USD 0.20

Bionoid Pharma Inc (BINP) Stock Forecast

N/A

Based on the Bionoid Pharma Inc stock forecast from 0 analysts, the average analyst target price for Bionoid Pharma Inc is not available over the next 12 months. Bionoid Pharma Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bionoid Pharma Inc is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Bionoid Pharma Inc’s stock price was USD 0.2. Bionoid Pharma Inc’s stock price has changed by -20.00% over the past week, -20.00% over the past month and -55.56% over the last year.

No recent analyst target price found for Bionoid Pharma Inc
No recent average analyst rating found for Bionoid Pharma Inc

Company Overview Bionoid Pharma Inc

Bionoid Pharma Inc. engages in the hemp cultivation business. The company is based in Beverly Hills, California.

https://bionoidpharma.com

433 North Camden, Beverly Hills, CA, United States, 90210

5

December

USD

USA

Adjusted Closing Price for Bionoid Pharma Inc (BINP)

Loading...

Unadjusted Closing Price for Bionoid Pharma Inc (BINP)

Loading...

Share Trading Volume for Bionoid Pharma Inc Shares

Loading...

Compare Performance of Bionoid Pharma Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BINP

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bionoid Pharma Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MKGAF
MERCK Kommanditgesellschaft au.. 0.00 (0.00%) USD81.10B 27.31 14.08

ETFs Containing BINP

Symbol Name BINP's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Bionoid Pharma Inc (BINP) Stock

Stock Target Advisor's fundamental analysis for Bionoid Pharma Inc's stock is Bearish.

Unfortunately we do not have enough data on BINP's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BINP's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BINP's stock to indicate if its overvalued.

The last closing price of BINP's stock was USD 0.20.

The most recent market capitalization for BINP is USD 0.01B.

Unfortunately we do not have enough analyst data on BINP's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Bionoid Pharma Inc's stock.

As per our most recent records Bionoid Pharma Inc has 5 Employees.

Bionoid Pharma Inc's registered address is 433 North Camden, Beverly Hills, CA, United States, 90210. You can get more information about it from Bionoid Pharma Inc's website at https://bionoidpharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...